Vidal M - Search Results

1

Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement.

Saci A, Liu WQ, Vidal M, Garbay C, Rendu F, Bachelot-Loza C. Saci A, et al. Among authors: vidal m. Biochem J. 2002 May 1;363(Pt 3):717-25. doi: 10.1042/0264-6021:3630717. Biochem J. 2002. PMID: 11964172 Free PMC article.

2

Differential interactions of the growth factor receptor-bound protein 2 N-SH3 domain with son of sevenless and dynamin. Potential role in the Ras-dependent signaling pathway.

Vidal M, Montiel JL, Cussac D, Cornille F, Duchesne M, Parker F, Tocqué B, Roques BP, Garbay C. Vidal M, et al. J Biol Chem. 1998 Feb 27;273(9):5343-8. doi: 10.1074/jbc.273.9.5343. J Biol Chem. 1998. PMID: 9478994 Free article.

3

A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity.

Cussac D, Vidal M, Leprince C, Liu WQ, Cornille F, Tiraboschi G, Roques BP, Garbay C. Cussac D, et al. Among authors: vidal m. FASEB J. 1999 Jan;13(1):31-8. doi: 10.1096/fasebj.13.1.31. FASEB J. 1999. PMID: 9872927

4

Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin.

Vidal M, Goudreau N, Cornille F, Cussac D, Gincel E, Garbay C. Vidal M, et al. J Mol Biol. 1999 Jul 16;290(3):717-30. doi: 10.1006/jmbi.1999.2899. J Mol Biol. 1999. PMID: 10395825

5

Small peptides containing phosphotyrosine and adjacent alphaMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domain.

Liu WQ, Vidal M, Gresh N, Roques BP, Garbay C. Liu WQ, et al. Among authors: vidal m. J Med Chem. 1999 Sep 9;42(18):3737-41. doi: 10.1021/jm9911074. J Med Chem. 1999. PMID: 10479306

6

Inhibition of the ras-dependent mitogenic pathway by phosphopeptide prodrugs with antiproliferative properties.

Liu WQ, Vidal M, Mathé C, Périgaud C, Garbay C. Liu WQ, et al. Among authors: vidal m. Bioorg Med Chem Lett. 2000 Apr 3;10(7):669-72. doi: 10.1016/s0960-894x(00)00077-9. Bioorg Med Chem Lett. 2000. PMID: 10762050

7

Inhibitors of Ras signal transduction as antitumor agents.

Garbay C, Liu WQ, Vidal M, Roques BP. Garbay C, et al. Among authors: vidal m. Biochem Pharmacol. 2000 Oct 15;60(8):1165-9. doi: 10.1016/s0006-2952(00)00428-7. Biochem Pharmacol. 2000. PMID: 11007954 Review.

8

SH2 and SH3 domains as targets for anti-proliferative agents.

Vidal M, Gigoux V, Garbay C. Vidal M, et al. Crit Rev Oncol Hematol. 2001 Nov;40(2):175-86. doi: 10.1016/s1040-8428(01)00142-1. Crit Rev Oncol Hematol. 2001. PMID: 11682324 Review.

9

Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.

Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A. Nioche P, et al. Among authors: vidal m. J Mol Biol. 2002 Feb 1;315(5):1167-77. doi: 10.1006/jmbi.2001.5299. J Mol Biol. 2002. PMID: 11827484

10

Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs.

Liu WQ, Vidal M, Olszowy C, Million E, Lenoir C, Dhôtel H, Garbay C. Liu WQ, et al. Among authors: vidal m. J Med Chem. 2004 Feb 26;47(5):1223-33. doi: 10.1021/jm031005k. J Med Chem. 2004. PMID: 14971902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,001 results

Search Page

Filters